PORTLAND, Ore., April 23, 2020 /PRNewswire/ -- VisCardia Inc., a privately held medical device developer, announced today it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its implantable VisONE® system designed for the treatment of...
from PR Newswire: https://ift.tt/2S0P8DO
No comments:
Post a Comment